AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BETA-ARTEMETHER
4 registrations across 3 African markets— 2 active
Markets with BETA-ARTEMETHER
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ARTENAM INJECTION | 🇷🇼Rwanda | SOLUPHARM GmbH | active | Sept 2029 |
| ARTEMETHER 80MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2014 |
| ARTENAM 50MG TABLET TABLET | 🇲🇼Malawi | — | expired | Oct 2004 |
| ARTENAM ampoule injectable / 100 mg | 🇸🇳Senegal | ARENCO | active | — |
BETA-ARTEMETHER in Africa — Regulatory Overview
BETA-ARTEMETHER is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Rwanda, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 2 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.